Cite
MLA Citation
Alberto M Borobia et al.. “Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.” Lancet, vol. 398, no. 10295, 2021, pp. 121–130. http://access.bl.uk/ark:/81055/vdc_100165516954.0x000050